CELZ
Creative Medical Technology Holdings, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q1 2026 | Q2 2026 | — | +0% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Feb 20, 2025 — the most recent Form 4 on file — not from today.
- Form 40001477932-25-001159Feb 20, 2025
- Form 40001477932-23-004914Jun 29, 2023
- Form 40001477932-22-008858Nov 23, 2022
- Form 40001477932-22-007311Sep 29, 2022
- Form 40001477932-22-007299Sep 28, 2022
- Form 40001477932-22-007108Sep 22, 2022
- Form 40001477932-22-004377Jun 14, 2022
- Form 40001477932-22-004177Jun 7, 2022
- Form 40001477932-22-003708May 20, 2022
- Form 40001477932-22-000693Feb 11, 2022
- Form 40001477932-22-000692Feb 11, 2022
- Form 40001477932-21-004848Jul 22, 2021
- Form 40001477932-21-004706Jul 16, 2021
- Form 40001477932-21-004705Jul 16, 2021
- Form 40001477932-21-004707Jul 16, 2021
Fundamentals
XBRL · Creative Medical Technology Holdings, Inc.Annual figures sourced directly from Creative Medical Technology Holdings, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QFORM 10-QMay 8, 2026
- 10-K/AFORM 10-K/AApr 24, 2026
- 10-KFORM 10-KMar 20, 2026
- 8-KFORM 8-KDec 31, 2025
- 8-KFORM 8-KDec 19, 2025
- S-3FORM S-3Nov 21, 2025
- DEF 14AProxy statementNov 13, 2025
- 8-KFORM 8-KNov 12, 2025
- 10-QFORM 10-QNov 7, 2025
- 8-KFORM 8-KOct 31, 2025
- DEF 14AProxy statementOct 30, 2025
- 10-QFORM 10-QAug 8, 2025
- 10-QFORM 10-QMay 9, 2025
- 8-KFORM 8-KMay 6, 2025
- 10-K/AFORM 10-K/AApr 25, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2025 | Q4 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.